谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase 1 Expansion Results of IDE397, a First-in-class, Oral, MAT2A Inhibitor (mat2ai) in MTAP Deleted(del) Non-Small Cell Lung Cancer (NSCLC) and Urothelial Cancer (UC)

B. Herzberg, M. Johnson,C. G. Kim,A. Tolcher,J. Rodon,C. Mantia, J. Liu, A. Tripathi, L. Paz-Ares Rodriguez, T. De la Motte Rouge,C. M. Choi, J. Y. Han, L. Kwei, E. Liu,J. Sachdev, M. O'Quigley, M. White,D. Beaupre,H. R. Kim

EUROPEAN JOURNAL OF CANCER（2024）

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要